Precision Diagnostics Pathnostics specializes in rapid, precision infectious disease and cancer diagnostics, with Guidance UTI delivering results in under a day. This presents an opportunity to partner with hospitals and outpatient networks seeking faster time-to-treatment and improved antibiotic stewardship.

Rapid Turnaround The company highlights fast reporting (less than 24 hours) and collaborations that reduce lab turnaround times. Target prospects include multi-site clinics and integrated delivery networks that require quick decision support to optimize patient care pathways.

Strategic Partnerships Past partnerships with Sunquest and Thermo Fisher indicate a readiness to integrate with lab information systems and multi-omics workflows. Use cases exist for expanding with LIS integrations, informatics platforms, and distribution partners to scale adoption.

Antibiotic Stewardship Guidance UTI emphasizes antibiotic stewardship, aligning with hospital goals to reduce inappropriate antibiotic use. This can drive conversations with hospital pharmacoeconomics teams, infection prevention committees, and payer strategies seeking value-based outcomes.

Growth & Investment With revenue in the tens of millions and prior growth investments, Pathnostics appears positioned for expansion in clinical networks and new markets. Sales plays could target mid-to-large hospitals, accountable care organizations, and regional health systems seeking scalable diagnostic solutions.